Novonesis is trading at 413.70 as of the 30th of November 2024, a 0.93 percent up since the beginning of the trading day. The stock's open price was 409.9. Novonesis has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Novonesis AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Although Novonesis' alpha and beta are two of the key measurements used to evaluate Novonesis' performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novonesis stock to make a market-neutral strategy. Peer analysis of Novonesis could also be used in its relative valuation, which is a method of valuing Novonesis by comparing valuation metrics with similar companies.